| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/13/2006 | US20060078544 generating an enhanced immune response to a prostate tumor associated antigen by administering a composition comprising allogeneic cancer cells that have been rendered proliferation-incompetent and have been genetically engineered to express granulocyte-macrophage colony stimulating factor (GM-CSF) |
| 04/13/2006 | US20060078543 Neural progenitor cells derived from embryonic stem cells |
| 04/13/2006 | US20060078542 Gel-based delivery of recombinant adeno-associated virus vectors |
| 04/13/2006 | US20060078540 Dendritic cell nodes |
| 04/13/2006 | US20060078537 Mono-and dual chemokine/cytokine constructs |
| 04/13/2006 | US20060078498 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192 |
| 04/13/2006 | CA2583431A1 Variant amyloid protein |
| 04/13/2006 | CA2581651A1 Cholesterol-labelled modified rna |
| 04/13/2006 | CA2562151A1 Oligonucleotides comprising a c5-modified pyrimidine |
| 04/12/2006 | EP1645635A2 Replication defective recombinant retroviruses expressing a palliative |
| 04/12/2006 | EP1645634A2 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/12/2006 | EP1645626A1 Cell line |
| 04/12/2006 | EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 04/12/2006 | EP1644496A2 Modified vectors for organelle transfection |
| 04/12/2006 | EP1644492A2 Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 04/12/2006 | EP1644048A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| 04/12/2006 | EP1644011A1 Conditioned matrix compositions for tissue restoration |
| 04/12/2006 | EP1578196A4 Mda-7 and free radicals in the treatment of cancer |
| 04/12/2006 | EP1540008A4 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 04/12/2006 | EP1485346A4 Novel positively charged lipids and liposomes comprising the positively charged lipids |
| 04/12/2006 | EP1409650B1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 04/12/2006 | EP1346230B1 Screening method based on tsap6 binding partners |
| 04/12/2006 | EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1181395B1 Method for the synthesis of dna fragments |
| 04/12/2006 | EP1118659B1 Expression systems for functional nucleic acid expression |
| 04/12/2006 | EP0985046B1 Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| 04/12/2006 | EP0832264B1 Plasmid for delivery of nucleic acids to cells and methods of use |
| 04/12/2006 | CN1759184A Expression vectors comprising the MCMV IE2 promoter |
| 04/12/2006 | CN1759182A Compositions and systems for the regulation of genes |
| 04/12/2006 | CN1759177A Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby |
| 04/12/2006 | CN1758924A Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 04/12/2006 | CN1757738A Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element |
| 04/12/2006 | CN1757398A Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026447 53 human secreted proteins |
| 04/11/2006 | US7026445 Human SDF-5 protein and compositions |
| 04/11/2006 | US7026300 One step immunization procedure for inducing a Chlamydia specific immune response |
| 04/11/2006 | US7026299 Stimulating angiogenesis enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing. |
| 04/11/2006 | US7026284 Formative agent of protein complex |
| 04/11/2006 | US7026162 Expression vector for use as tool in genetic engineering |
| 04/11/2006 | US7026154 Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses |
| 04/11/2006 | US7026140 Serum paraoxonase |
| 04/11/2006 | US7026139 To regulate an immune response in an animal |
| 04/11/2006 | US7026113 Veterinary medicine; vaccine containing mutant gene |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/11/2006 | US7025968 Identifying viricidal agents which prevent cytomegalo viral infection and distribution; gene expression inhibition |
| 04/11/2006 | US7025967 Recombinant protein production in bovine adenovirus expression vector system |
| 04/11/2006 | CA2204375C Methods for the diagnosis of glaucoma |
| 04/11/2006 | CA2200952C Novel compositions comprising quaternary ammonium compounds and neutral lipids for the introduction of polyanionic materials into cells |
| 04/06/2006 | WO2006037126A2 Method of treating an inflammatory disease by double stranded ribonucleic acid |
| 04/06/2006 | WO2006037029A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 04/06/2006 | WO2006036916A2 Rnai modulation of apob and uses thereof |
| 04/06/2006 | WO2006036502A2 Improved expression of factor ix in gene therapy vectors |
| 04/06/2006 | WO2006036004A1 Telomelysin-gfp gene-containing recombinant virus |
| 04/06/2006 | WO2006035974A1 Oligoribonucleotide |
| 04/06/2006 | WO2006035434A2 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
| 04/06/2006 | WO2006035432A2 Gene silencing for use in dermatology |
| 04/06/2006 | WO2006017857A9 Antibiotic resistance free dna vaccines |
| 04/06/2006 | WO2006013457A3 Gad2 gene for possible treatment of nervous system disorders |
| 04/06/2006 | WO2006004988A3 B7-dc binding antibody |
| 04/06/2006 | WO2005099772A3 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death |
| 04/06/2006 | WO2005097206A3 Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano |
| 04/06/2006 | WO2005004794A8 Method of treating neurodegenerative disease |
| 04/06/2006 | WO2004094610A3 Wnt as a factor for cardiac myogenesis |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074045 Vector for transfection of eukaryotic cells |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074043 Antisense modulation of matrix metalloproteinase 1 expression |
| 04/06/2006 | US20060074042 Highly hypoxia-specific gene expression system for ischemic gene therapy |
| 04/06/2006 | US20060074041 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 04/06/2006 | US20060074040 Administering an immunostimulatory oligonucleotide or an immunomer compound and treating with ionizing or gamma radiation; antiinflammatory, anticarcinogenic, antitumor, antihistamine, antiallergen, and bronchodilator agents; autoimmune, respiratory system, and skin disorders; cytokine immunotherapy |
| 04/06/2006 | US20060074038 Her-2 neu dna vaccine having anti-cancer activity |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060074036 Agents for gene therapy of cerebrovascular disorders |
| 04/06/2006 | US20060074034 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
| 04/06/2006 | US20060074033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073596 Oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers; non-toxic and effective in low doses |
| 04/06/2006 | US20060073595 Recombinant Adenoviruses which function as helper viruses to gutted Ad viruses lacking viral coding sequences; gene therapy |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073564 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) |
| 04/06/2006 | US20060073552 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073512 Genomic sequence of the purH gene and purH-related biallelic markers |
| 04/06/2006 | US20060073492 Prediction and predisposition of MBL gene to bronchial asthma with allergic rhinitis |
| 04/06/2006 | US20060073478 Atlastin |
| 04/06/2006 | US20060073159 Human anti-cancer immunotherapy |
| 04/06/2006 | US20060073151 Inhibitors of extracellular Hsp90 |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073134 Determining in a pancreas sample the level of expression of a marker protein; islet cell regeneration factor; lithostathine 1 alpha, leukocyte elastase inhibitor, lipocalin-2; indicates diabetes |
| 04/06/2006 | US20060073128 Means and methods for the modulation of arteriogenesis |
| 04/06/2006 | US20060073127 Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules |
| 04/06/2006 | US20060073126 Cytotoxic T lymphocyte |